Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab

JAMA Neurology

Volumn 70, Issue 3, 2013, Pages 398-402

  Boster, Aaron L ^a   Nicholas, Jacqueline A ^a   Topalli, Ilir ^b   Kisanuki, Yaz Y ^a   Pei, Wei ^a   Morgan Followell, Bethanie ^a   Kirsch, Laudia F ^a   Racke, Michael K ^a   Pitt, David ^a  

^a Boston University Medical Campus   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CD68 ANTIGEN; CORTICOSTEROID; GLIAL FIBRILLARY ACIDIC PROTEIN; NATALIZUMAB; PROTEIN VP1; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY LABELING; ARTICLE; ASTROCYTE; AUTOPSY; BLINDNESS; CASE REPORT; CAUCASIAN; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DRUG FATALITY; DRUG INFUSION; DRUG MEGADOSE; DRUG SUBSTITUTION; EXPANDED DISABILITY STATUS SCALE; HEMIPLEGIA; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; JC VIRUS; MACROPHAGE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUADRIPLEGIA; RISK BENEFIT ANALYSIS; TERTIARY HEALTH CARE; WHITE MATTER DEMYELINATION; WHITE MATTER LESION;

EID: 84874851868     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.1960     Document Type: Article

References (10)

1. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001;50(3):389-400.
2. Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 2011;365(23):21882197.
3. Wuthrich C, Koralnik IJ. Frequent infection of cortical neurons by JC virus in patientswith progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2012;71(1):54-65.
4. Burman J, Raininko R, Fagius J. Bilateral and recurrent optic neuritis in multiple sclerosis. Acta Neurol Scand. 2011;123(3):207-210.
5. Matthews WB, Acheson ED, Batchelor JR, Weller RO, eds. McAlpine's Multiple Sclerosis. White Plains, NY: Churchill Livingstone; 1985:153.
6. Stuve O, Marra CM, Jerome KR, et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol. 2006;59(5):743-747.
7. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab- associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012;366(20): 1870-1880.
8. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology. 1999; 52(2):253-260.
9. Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008;26(3): 833-854, x-xi.
10. Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol. 2010;68(3):384-391.